Home

Insights

Glaxosmithkline Pharmaceuticals Ltd dividend

Glaxosmithkline Pharmaceuticals Ltd dividend

download
stocks purchased

₹ 2.0 Cr

Volume transacted

stocks purchased

8.6 K

stocks traded

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

DPS

32

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Glaxosmithkline Pharmaceuticals Ltd is ₹ 32 as of 2023 .a1#The Dividend Payout of Glaxosmithkline Pharmaceuticals Ltd changed from 79.65 % on March 2019 to 89.2 % on March 2023 . This represents a CAGR of 2.29% over 5 years. a1#The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2355 as of 18 May 15:30 .a1#The Market Cap of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 22020 crore on March 2019 to ₹ 22431 crore on March 2023 . This represents a CAGR of 0.37% over 5 years. a1#The Revenue of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 775.76 crore to ₹ 962.03 crore over 8 quarters. This represents a CAGR of 11.36% a1#The EBITDA of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 179.58 crore to ₹ 289.49 crore over 8 quarters. This represents a CAGR of 26.97% a1#The Net Profit of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 119.28 crore to ₹ 194.48 crore over 8 quarters. This represents a CAGR of 27.69% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield

swot
swot

Fundamental Metrics

Market Cap

34,285 Cr

EPS

37.9

P/E Ratio (TTM) *

53.5

P/B Ratio (TTM) *

22.3

DTE *

0.0

ROE *

42.1

ROCE *

57.4

Dividend Yield *

2.42

DPS *

32

Dividend Payout *

89.2

Ann.Dividend % *

320

* All values are consolidated

* All values are consolidated

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1980
Mar '20616
Mar '21142
Mar '2290
Mar '2389

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PRICE

2355.75

64.20(2.80%)

stock direction

Last updated : 18 May 15:30

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

0

S

Weakness

4

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Dividend Overview for Glaxosmithkline Pharmaceuticals Ltd

  • Glaxosmithkline Pharmaceuticals Ltd, boasts of a market capitalization of Rs 34285 Cr., with a share price of Rs 2355.75 as of 18 May 15:30. While all stocks don't consistently pay dividends, Glaxosmithkline Pharmaceuticals Ltd rewarded its shareholders, distributing 89.2 % for the full year.
  • In the year ending 2022, Glaxosmithkline Pharmaceuticals Ltd declared a dividend of Rs 90, resulting in a dividend yield of 5.4% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Glaxosmithkline Pharmaceuticals Ltd recorded revenues of Rs 3311 Cr, with a trailing EBITDA Margin of 24.3% and net-profit of Rs 529 Cr

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1922020
Mar '2021095
Mar '2124401
Mar '2228171
Mar '2322432

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '22776
Sep '22939
Dec '22826
Mar '22826
Jun '23815
Sep '23985
Dec '23833
Mar '23962

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '22180
Sep '22279
Dec '22241
Mar '22208
Jun '23198
Sep '23318
Dec '2383
Mar '23289

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '22119
Sep '22193
Dec '22165
Mar '22133
Jun '23132
Sep '23218
Dec '2346
Mar '23194

* All values are a in crore

About Glaxosmithkline Pharmaceuticals Ltd

About Glaxosmithkline Pharmaceuticals Ltd

    It is a subsidiary of GlaxoSmithKline plc, UK, one of the world's leading research-based pharmaceutical and healthcare companies. In 1961, the Company started manufacturing Vitamin A and Betamethasone at new plant at Thane using imported raw materials. The company's name was changed from Glindia Ltd to Glaxo India Ltd. In the year 1990, the production of the bulk drug, cephalexin was commenced at Ankleshwar and the salbutamol inhalers at Nashik. They increased the production capacity of Solids including Powders and Ointments from 1550 tonnes to 2225 tonnes. Formulations of Atorvastatin and Rosuvastatin tablets were launchec in Cardiology under the brand names 'Lilo' and 'Rosutec' respectively. This follows a global transaction between GlaxoSmithKline plc, UK (GSK) and Novartis AG, Switzerland (Novartis) which was completed in March 2015 on the same basis. During the quarter ended 30 September 2016, the company successfully launched Priorix-Tetra, a combined measles, mumps, rubella and varicella vaccine. During the quarter ended 31 December 2017, the company received the money in advance towards disposal of Thane land. During the quarter ended 31 March 2018, the company successfully launched Biopatch, a hydrophilic wound dressing that is used to cover a wound caused by the use of percutaneous medical devices.

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

17 May 2024 14:03

News

GlaxoSmithKline Pharmaceuticals to conduct AGM

GlaxoSmithKline Pharmaceuticals announced that the 99th Annual General Meeting(AGM) of the...

Read more

17 May 2024 16:48

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

20 Apr 2024 18:27

News

Glaxosmithkline Pharmaceuticals Ltd slips for fifth straight session

Glaxosmithkline Pharmaceuticals Ltd is down for a fifth straight session today. The stock ...

Read more

11 Mar 2024 13:35

News

GSK Pharma slumps as PAT drops 72% YoY in Q3 FY24

Revenue from operations rose marginally to Rs 805.26 crore in the quarter ended 31 Decembe...

Read more

13 Feb 2024 10:41

News

Glaxosmithkline Pharmaceuticals Ltd slips for fifth straight session

Glaxosmithkline Pharmaceuticals Ltd is down for a fifth straight session today. The stock ...

Read more

13 Feb 2024 13:35

FAQs for dividends of Glaxosmithkline Pharmaceuticals Ltd

What is the current market price of Glaxosmithkline Pharmaceuticals Ltd Ltd as of May 18, 2024?

The current market price of Glaxosmithkline Pharmaceuticals Ltd Ltd stands at 2355.8 per share.

What dividend did Glaxosmithkline Pharmaceuticals Ltd declare in the last fiscal year?

In the last fiscal year, Glaxosmithkline Pharmaceuticals Ltd declared a dividend totaling ₹32.0.

What is the most recent dividend declared by Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Glaxosmithkline Pharmaceuticals Ltd declared dividends in the current fiscal year

Glaxosmithkline Pharmaceuticals Ltd has declared dividends 4 times totaling ₹32 in the current fiscal year (FY2023-2024).

How many times did Glaxosmithkline Pharmaceuticals Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Glaxosmithkline Pharmaceuticals Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199